Quinn-Allen M - Search Results

1

Deletion analysis of recombinant human factor V. Evidence for a phosphatidylserine binding site in the second C-type domain.

Ortel TL, Devore-Carter D, Quinn-Allen M, Kane WH. Ortel TL, et al. J Biol Chem. 1992 Feb 25;267(6):4189-98. J Biol Chem. 1992. PMID: 1740460 Free article.

2

Trp2063 and Trp2064 in the factor Va C2 domain are required for high-affinity binding to phospholipid membranes but not for assembly of the prothrombinase complex.

Peng W, Quinn-Allen MA, Kim SW, Alexander KA, Kane WH. Peng W, et al. Among authors: quinn allen ma. Biochemistry. 2004 Apr 13;43(14):4385-93. doi: 10.1021/bi035763o. Biochemistry. 2004. PMID: 15065883

3

Identification of the MMRN1 binding region within the C2 domain of human factor V.

Jeimy SB, Woram RA, Fuller N, Quinn-Allen MA, Nicolaes GA, Dahlbäck B, Kane WH, Hayward CP. Jeimy SB, et al. Among authors: quinn allen ma. J Biol Chem. 2004 Dec 3;279(49):51466-71. doi: 10.1074/jbc.M409866200. Epub 2004 Sep 27. J Biol Chem. 2004. PMID: 15452129 Free article.

4

The phosphatidylserine binding site of the factor Va C2 domain accounts for membrane binding but does not contribute to the assembly or activity of a human factor Xa-factor Va complex.

Majumder R, Quinn-Allen MA, Kane WH, Lentz BR. Majumder R, et al. Among authors: quinn allen ma. Biochemistry. 2005 Jan 18;44(2):711-8. doi: 10.1021/bi047962t. Biochemistry. 2005. PMID: 15641797

5

A phosphatidylserine binding site in factor Va C1 domain regulates both assembly and activity of the prothrombinase complex.

Majumder R, Quinn-Allen MA, Kane WH, Lentz BR. Majumder R, et al. Among authors: quinn allen ma. Blood. 2008 Oct 1;112(7):2795-802. doi: 10.1182/blood-2008-02-138941. Epub 2008 Jun 27. Blood. 2008. PMID: 18587009 Free PMC article.

6

Modulation of prothrombinase assembly and activity by phosphatidylethanolamine.

Majumder R, Liang X, Quinn-Allen MA, Kane WH, Lentz BR. Majumder R, et al. Among authors: quinn allen ma. J Biol Chem. 2011 Oct 14;286(41):35535-35542. doi: 10.1074/jbc.M111.260141. Epub 2011 Aug 22. J Biol Chem. 2011. PMID: 21859710 Free PMC article.

7

Characterization of an acquired inhibitor to coagulation factor V. Antibody binding to the second C-type domain of factor V inhibits the binding of factor V to phosphatidylserine and neutralizes procoagulant activity.

Ortel TL, Quinn-Allen MA, Charles LA, Devore-Carter D, Kane WH. Ortel TL, et al. J Clin Invest. 1992 Dec;90(6):2340-7. doi: 10.1172/JCI116123. J Clin Invest. 1992. PMID: 1281831 Free PMC article.

8

Localization of functionally important epitopes within the second C-type domain of coagulation factor V using recombinant chimeras.

Ortel TL, Quinn-Allen MA, Keller FG, Peterson JA, Larocca D, Kane WH. Ortel TL, et al. J Biol Chem. 1994 Jun 3;269(22):15898-905. J Biol Chem. 1994. PMID: 7515064 Free article.

9

Thrombin-catalyzed activation of recombinant human factor V.

Keller FG, Ortel TL, Quinn-Allen MA, Kane WH. Keller FG, et al. Biochemistry. 1995 Mar 28;34(12):4118-24. doi: 10.1021/bi00012a030. Biochemistry. 1995. PMID: 7696276

10

Partial glycosylation at asparagine-2181 of the second C-type domain of human factor V modulates assembly of the prothrombinase complex.

Kim SW, Ortel TL, Quinn-Allen MA, Yoo L, Worfolk L, Zhai X, Lentz BR, Kane WH. Kim SW, et al. Biochemistry. 1999 Aug 31;38(35):11448-54. doi: 10.1021/bi991275y. Biochemistry. 1999. PMID: 10471296

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters